- Home
- AMR vs IOVA Comparison
AMR vs IOVA Comparison
Compare AMR & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMR
- IOVA
- Stock Information
- Founded
- AMR 2016
- IOVA 2007
- Country
- AMR United States
- IOVA United States
- Employees
- AMR N/A
- IOVA N/A
- Industry
- AMR Coal Mining
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AMR Energy
- IOVA Health Care
- Exchange
- AMR Nasdaq
- IOVA Nasdaq
- Market Cap
- AMR 1.9B
- IOVA 975.1M
- IPO Year
- AMR N/A
- IOVA N/A
- Fundamental
- Price
- AMR $143.11
- IOVA $2.27
- Analyst Decision
- AMR Buy
- IOVA Buy
- Analyst Count
- AMR 3
- IOVA 11
- Target Price
- AMR $160.50
- IOVA $11.90
- AVG Volume (30 Days)
- AMR 331.4K
- IOVA 11.1M
- Earning Date
- AMR 10-31-2025
- IOVA 11-06-2025
- Dividend Yield
- AMR N/A
- IOVA N/A
- EPS Growth
- AMR N/A
- IOVA N/A
- EPS
- AMR N/A
- IOVA N/A
- Revenue
- AMR $2,371,475,000.00
- IOVA $241,525,000.00
- Revenue This Year
- AMR N/A
- IOVA $67.40
- Revenue Next Year
- AMR $22.30
- IOVA $56.32
- P/E Ratio
- AMR N/A
- IOVA N/A
- Revenue Growth
- AMR N/A
- IOVA 636.99
- 52 Week Low
- AMR $97.41
- IOVA $1.64
- 52 Week High
- AMR $255.04
- IOVA $12.51
- Technical
- Relative Strength Index (RSI)
- AMR 53.01
- IOVA 45.40
- Support Level
- AMR $138.00
- IOVA $2.27
- Resistance Level
- AMR $145.00
- IOVA $2.46
- Average True Range (ATR)
- AMR 5.45
- IOVA 0.15
- MACD
- AMR -0.89
- IOVA -0.00
- Stochastic Oscillator
- AMR 52.65
- IOVA 29.09
About AMR Alpha Metallurgical Resources Inc.
Alpha Metallurgical Resources Inc is a Tennessee-based coal mining company with operations across Virginia and West Virginia. The company's portfolio of mining operations consists of underground mines, surface mines, and coal preparation plants. It produces low-ash metallurgical coal, including High-Vol. A, Mid-Vol., High-Vol. B, and Low-Vol. coal, which is shipped to domestic and international coke and steel producers. The reportable segment of the company is Met. It extracts, processes and markets met and thermal coal from deep and surface mines for sale to steel and coke producers, industrial customers, and electric utilities.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.